Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the efficacy of agomelatine compared to placebo on the reduction of
Obsessive and Compulsive symptoms after 16 weeks of treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Institut de Recherches Internationales Servier Servier